期刊文献+

丙泊酚对肺动脉高压患者肺循环的影响 被引量:2

Effects of Propofol on Pulmaonary Circulation in Patients with Pulmonary Hypertension
下载PDF
导出
摘要 肺动脉高压是一类预后很差的综合征,尽管药物治疗有所发展,但至今仍没有很好的治疗方法。手术及麻醉过程中的很多因素可引起肺血管阻力增高,如缺氧、手术刺激、炎性介质等,对于手术过程中有肺动脉高压的患者选择合适的麻醉药维持循环稳定,防止肺循环阻力进一步增高至关重要。丙泊酚是一种常用的静脉麻醉药,现综述丙泊酚对肺动脉高压手术患者肺循环的影响,探讨丙泊酚用于肺动脉高压患者麻醉中的益处。 Pulmonary artetial hypertension(PAH) is a kind of syndrome with poor progonosis,although novel drugs have been developed,the chance of survival remains poor.Many factors can cause pulmonary artery pressure to increase,such as hypoxia,operation stimulation,mediators of inflammation,and so on.It is very important to maintain circulation stabilization and prevent further increase of pulmonary artery pressure by choosing right anesthetics.Propofol,an intravenous anesthetic,is most common in clinical use.Here is to summarize the effects of propofol on pulmonary circulation in patients with PAH under operation to discuss the benefits of propofol in such cases.
出处 《医学综述》 2013年第5期875-877,共3页 Medical Recapitulate
关键词 肺动脉高压 二丙泊酚 麻醉 Pulmanory hypertension Propofol Anesthesia
  • 相关文献

参考文献27

  • 1GalièN,Palazzini M,Manes A.Pulmonary hypertension and pul-monary arterial hypertension:a clarification is needed[J].Eur Re-spir J,2010,36(5):986-990.
  • 2Humbert M,Sitbon O,Chaouat A,et al.Survival in patients withidiopathic,familial,and anorexigen-associated pulmonary arterialhypertension in the modern management era[J].Circulation,2010,122(2):156-163.
  • 3Searle NR,Sahab P.Propofol in patients with cardiac disease[J].Can J Anaesth,1993,40(8):730-747.
  • 4Nagakawa T,Yamazaki M,Hatakeyama N,et al.The mechanismsof propofol-mediated hyperpolarization of in situ rat mesenteric vas-cular smoth muscle[J].Anesth Analg,2003,97(6):1639-1645.
  • 5Aytekin M,Caylak E.Pulmonary arterial hypertension:past,presentand future[J].Tuberk Toraks,2010,58(1):100-107.
  • 6Bonnet S,Archer SL.Potassium channel diversity in the pulmonaryar teries and pulmonary veins:implications for regulation of thepulmonary vasculature in health and during pulmonary hyperten-sion[J].Pharmacol Ther,2007,115(1):56-69.
  • 7Li M,Stenmark KR,Shandas R,et al.Effects of pathological flowon pulmonary artery endothelial production of vasoactive mediatorsand growth factors[J].J Vasc Res,2009,46(6):561-571.
  • 8Price LC,Wort SJ,Perros F,et al.Inflammation in pulmonary arte-rial hypertension[J].Chest,2012,141(1):210-221.
  • 9Li W,Dunmore BJ,Morrell NW.Bone morphogenetic protein typeII receptor mutations causing protein misfolding in heritable pulmo-nary arterial hypertension[J].Proc Am Thorac Soc,2010,7(6):395-3958.
  • 10Uezono S,Clarke WR.The effect of propofol on normal and in-creased pulmonary vascularr esistance in isolated perfused rabbitlung[J].Anesth Analg,1995,3(80):577-582.

二级参考文献44

共引文献25

同被引文献50

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部